This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Evolving Approaches to Early-Stage Drug Discovery
joint with Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
Organizer(s): Craig W. Lindsley and Linda Brady
Date: April 03 - 07, 2011
Location: Snowbird Resort, Snowbird, UT, USA
Sponsored by Bayer USA Foundation and Gilead Sciences, Inc.
Summary of Meeting:
This meeting will cover multiple aspects of the challenges and opportunities facing drug discovery scientists. These challenges include: 1) diverse approaches to early stage discovery in a resource constrained environment, 2) evolution of preclinical drug discovery in academia, 3) evolution of drug leads and target validation from the NIH (MLPCN), 4) funding early stage or risky programs, 5) external licensing of programs and 6) advances in biomarkers and imaging to enable target selection and rapid go, no-go decisions. The meeting goals are to bring together experts in all of these areas, present findings and opinions, and initiate dialog on these topics. This will be the first meeting to bring together drug discovery scientists form big Pharma, biotech, academia, the MLPCN and Foundations – each with unique missions and approaches – to provide a forum for sharing their respective experiences.
Scholarship Deadline: December 2 2010
Discounted Abstract Deadline: December 2 2010
Abstract Deadline: January 4 2011
Discounted Registration Deadline: February 3 2011
We gratefully acknowledge additional support for this conference from:
Bayer USA FoundationBioMarin Pharmaceutical Inc.Gilead Sciences, Inc.Myriad-RBM
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Eli Lilly and Company

Epizyme, Inc.

Merck Vaccine Division

Pfizer Global Research & Development
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Mental Health (NIMH)
Grant No. 1R13MH094126-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found